Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Feb 6, 2021; 9(4): 792-800
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.792

Table 2 Baseline data of patients from the two groups (n = 26)

Clinicopathologic feature	Non-chemotherapy (n = 19)	Chemotherapy (n = 7)	P value
Mean age (rang), yr	60.74 (38-81)	59.86 (48-70)	0.841
Sex, M/F			0.715
Male	14	4
Female	5	3
Tumor location in the pancreas			1.000
Head	12	5
Neck and body	5	1
Tail	2	1
Palliative operation			0.505
Choledochojejunostomy	8	3
Choledochojejunostomy and gastroenterostomy	1	2
1-yr survival rate (%)	15.8	68.6	0.012

Citation: Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY. Radioactive ¹²⁵I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients. World J Clin Cases 2021; 9(4): 792-800
URL: https://www.wjgnet.com/2307-8960/full/v9/i4/792.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i4.792

Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY. Radioactive ¹²⁵I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients. World J Clin Cases 2021; 9(4): 792-800 [PMID: 33585625 DOI: 10.12998/wjcc.v9.i4.792]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.